Albumin Market Trends 2025 Significant surge in non-therapeutic application of albumin, increasing production of immunoglobulins & plasma c ...
Zacks Small Cap Research on MSN14d
DYAI: Looking Toward Product Revenues
DYAI READ THE FULL DYAI RESEARCH REPORT Dyadic International Inc. (NASDAQ:DYAI) enters 2025 on the cusp of generating product revenues from its relationship with Proliant. Initially, commercialization ...
Recombinant albumin is gaining prominence due to its ... Clinical Use in Fluid Replacement Therapy: Human serum albumin is essential for fluid replacement therapy in critically ill patients ...
Initially, commercialization efforts and sales will be focused on recombinant serum albumin. Further down the ... enumerated many of the key products in human health where it can contribute ...